Schedule 13G ownership disclosure
Celldex Therapeutics Inc
Common Stock · CUSIP: 15117B202
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Wellington Management Group LLP
Shares: 5,232,326.00 · Class: 7.9%
- Wellington Group Holdings LLP
Shares: 5,232,326.00 · Class: 7.9%
- Wellington Investment Advisors Holdings LLP
Shares: 5,232,326.00 · Class: 7.9%
- Wellington Management Company LLP
Shares: 5,232,326.00 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-25-000286
- Form type
- SCHEDULE 13G/A
- Filer
- Celldex Therapeutics, Inc.
- CIK
- CIK 744218
- Filed
- Aug 12, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership